Lose The Fat is your online resource for getting in shape, we look at the latest diet news and provide advice from experts to help acheive your goals.

Tags: acomplia


A new weight loss drug that has been hailed as the latest treatment to fight obesity in England, is to be evaluated by health authorities in New Zealand.


The pill, Acomplia, made by the French pharmaceutical firm Sanofi-Aventis, is thought to help curb a person's appetite and to help reduce the risk of diabetes and heart disease.


Dubbed 'the wonder pill', studies have found that it cuts body weight by up to 10 percent within one year.

Available through a prescription in the UK, now the drug is to be marketed in New Zealand.
The drug is currently under evaluation by health officials in New Zealand.


According to the New Zealand Herald, the drug has been hailed as a breakthrough in treating obesity by some in the medical fraternity overseas on the basis of interim study results.



Source: All Headline News


Add to Google
Technorati tags: acompliasanofi-aventisweight loss drug

A revolutionary new drug which helps people lose weight has been launched in the UK.


It causes weight loss by blocking the brain's craving signals, suppressing the appetite.


It is the first drug of its kind because as well as aiding weight loss, it also regulates diabetes and manages cholesterol.
The drug, called Acomplia, is made by the French pharmaceutical firm Sanofi-Aventis, and has been used successfully in clinical trials.


The results revealed patients who took the drug lost weight and their waistlines shrank.

Professor John Betteridge, a leader in the field of medicine who reviewed the clinical trials, said the results were "fascinating".

He said:

"This is a useful new medicine to help overweight people at risk of heart attacks. After a year, people on the trial had lost up to eight kilograms. It is particularly effective at reducing weight around the waist.
"For overweight people, it is important to change lifestyle first but for some that doesn't work so this new medicine will help them."




A tablet must be taken every morning before breakfast but for the best results, doctors also recommend patients follow a reduced-calorie diet and exercise regularly.


The pills are available from today on prescription from GPs and privately after being given the EU seal of approval. However, GPs will only prescribe it to obese people with other risk factors such as diabetes.

A spokeswoman for Sanofi-Aventis said:

"We believe the right patient for Acomplia is overweight with type two diabetes or low levels of good cholesterol (HDL) or high levels of bad blood fats.
"It will benefit these people the most because it will also provide improvement above and beyond weight loss alone."




Source: The Sun Online


Add to Google